Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BLTE
#1121
Belite Bio, Inc American Depositary Shares
171.9
3
USD
-0.72%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.72%
Monthly Change
+4.77%
6 month change
+114.91%
Year Change
+193.75%
Previous Close
173.1
8
Open
171.9
3
Bid
Ask
Low
171.9
3
High
171.9
3
Volume
13
Markets
US Stock Market
Healthcare
BLTE
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
24.9 M
29.15 M
31.83 M
39.34 M
125.21 M
Valuation ratios
Enterprise value
700.76 M
1.16 B
1.98 B
5.94 B
9.78 B
Price to earnings ratio
-47.3
-35.93
-53.47
-69.25
-205.96
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
-51.96
-38.11
-65.92
-145.04
-301.02
Price to book ratio
14.34
12.57
13.21
6.96
47.1
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.29
-0.33
-0.24
-0.1
-0.93
Return on equity %
-0.3
-0.35
-0.25
-0.1
-0.98
Return on invested capital %
-3 082.21
-3 797.06
-3 089.6
-230.8
—
Gross margin %
—
—
—
—
—
Operating margin %
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
20.35
24.76
24.31
50.02
119.43
Inventory turnover
—
—
—
—
—
Asset turnover
—
—
—
—
—
Solvency ratios
Debt to assets ratio
0.02
—
—
—
—
Debt to equity ratio
0.02
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
Per share metrics
Operating cash flow per share
-0.57
-1.12
-0.96
-1.1
-4.78
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
0.04
—
—
—
—
Cash per share
2.11
3.31
4.75
14.68
24.86
Net current asset value per share
2.14
3.38
4.82
14.74
25.08
Tangible book value per share
2.08
3.4
4.77
22.97
33.22
Working capital per share
2.04
3.25
4.62
14.44
24.34
Book value per share
2.08
3.4
4.78
22.97
33.23
News
Belite Bio at Leerink Conference: Tinlarebant’s Promising Trials
Mizuho reiterates Belite Bio stock rating on NDA timeline update
H.C. Wainwright raises Belite Bio stock price target on NDA timeline
Belite Bio, Inc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BLTE) 2026-03-03
Belite Bio stock price target raised to $217 by Benchmark on trial data
Cantor Fitzgerald raises Belite Bio stock price target on pricing outlook
Belite Bio, Inc (BLTE) Q4 2025 Earnings Call Transcript
Belite Bio stock hits all-time high at 177.28 USD
H.C. Wainwright reiterates Buy rating on Belite Bio stock with $185 target
Belite Bio completes enrollment in phase 2/3 STGD1 drug trial
Belite Bio stock hits all-time high at $170.35
BofA Securities initiates coverage on Belite Bio stock with Buy rating